News

Monday, September 12, 2016/Author: Elin Aslanyan/Number of views (2251)/Comments ()/
Categories: Latest News
September Is Rheumatic Disease Awareness Month

September Is Rheumatic Disease Awareness Month

September 2016 marks the first annual Rheumatic Disease Awareness Month (RDAM.) The campaign is an effort to increase public understanding and awareness of the symptoms, risk factors, treatment options, personal and economic impact, and the lifestyle and healthcare challenges associated with rheumatic diseases, such as spondylitis.
Wednesday, September 07, 2016/Author: SAA Administrator/Number of views (3693)/Comments ()/
Categories: Latest News
My Experience at the SPARTAN Conference

My Experience at the SPARTAN Conference

Comprised of spondylitis clinicians and researchers, SPARTAN (the Spondyloarthritis Research and Treatment Network) meets each year to discuss new research.

Thursday, August 18, 2016/Author: Richard Howard/Number of views (1219)/Comments ()/
Categories: Latest News
Tuesday, July 19, 2016/Author: Spondylitis Association of America/Number of views (1537)/Comments ()/
Categories: Latest News
Tags:
FDA Advisory Committee Unanimously Recommends Approval of a Biosimilar Version of Humira (Adalimumab) for Ankylosing Spondylitis, Psoriatic Arthritis, and More.

FDA Advisory Committee Unanimously Recommends Approval of a Biosimilar Version of Humira (Adalimumab) for Ankylosing Spondylitis, Psoriatic Arthritis, and More.

The FDA Arthritis Advisory Committee voted unanimously on July 12 in favor of approving Amgen’s biosimilar version of AbbVie’s Humira (adalimumab.)

Wednesday, July 13, 2016/Author: Spondylitis Association of America/Number of views (2324)/Comments ()/
Categories: Latest News
RSS
12345678910Last